Human antibodies specific for interleukin 15 (IL-15)

Details for Australian Patent Application No. 2004215120 (hide)

Owner Genmab A/S

Inventors Baadsgaard, Ole D. M. Sc.; Van De Winkel, Jan G. J.; Gerritsen, Arnout F.; Van Dijk, Marcus Antonius; Schuurman, Janine; Petersen, Jorgen

Agent Watermark

Pub. Number AU-B-2004215120

PCT Pub. Number WO2004/076620

Priority 10/374,932 26.02.03 US; 10/379,741 05.03.03 US

Filing date 25 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 28 July 2011

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

15 September 2005 PCT application entered the National Phase

  PCT publication WO2004/076620 Priority application(s): WO2004/076620

28 July 2011 Application Accepted

  Published as AU-B-2004215120

11 August 2011 Corrigenda

  Applications Accepted - Name Index Under the name Genmab A/S, Application No. 2004215120, under INID (72) correct the co-inventor to Baadsgaard, Ole Corrigenda

24 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004215125-Monoclonal antibody production by EBV transformation of B cells

2004215118-Secondary cutting element for drill bit